MiGenTra

MiGenTra is a medical innovation pharmaceutical company jointly established by biopharmaceutical company ProBioGen and Minapharm Pharmaceuticals, and operates as a subsidiary under ProBioGen. MiGenTra combines the scientific and manufacturing expertise of its two investor companies, ProBioGen and Minapharm Pharmaceuticals. The company is dedicated to the development and commercialization of products in the fields of biosimilars, cell and gene therapies (CGT), and vaccines, fully leveraging ProBioGen's robust development capabilities and Minapharm's strong market position in the region.